Biblio

Export 3292 results:
Author [ Title(Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
M. Kolarova, Sengupta, U., Bartos, A., Ricny, J., and Kayed, R., Tau Oligomers in Sera of Patients with Alzheimer's Disease and Aged Controls., J Alzheimers Dis, vol. 58, no. 2, pp. 471-478, 2017.
Y. Li, Li, Z. - X., Jin, T., Wang, Z. - Y., and Zhao, P., Tau Pathology Promotes the Reorganization of the Extracellular Matrix and Inhibits the Formation of Perineuronal Nets by Regulating the Expression and the Distribution of Hyaluronic Acid Synthases., J Alzheimers Dis, vol. 57, no. 2, pp. 395-409, 2017.
A. Slachevsky, Guzmán-Martínez, L., Delgado, C., Reyes, P., Farías, G. A., Muñoz-Neira, C., Bravo, E., Farías, M., Flores, P., Garrido, C., Becker, J. T., Lopez, O. L., and Maccioni, R. B., Tau Platelets Correlate with Regional Brain Atrophy in Patients with Alzheimer's Disease., J Alzheimers Dis, vol. 55, no. 4, pp. 1595-1603, 2017.
R. Pluta, Ułamek-Kozioł, M., Januszewski, S., and Czuczwar, S. J., Tau Protein Dysfunction after Brain Ischemia., J Alzheimers Dis, vol. 66, no. 2, pp. 429-437, 2018.
W. A. Banks, Kovac, A., Majerova, P., Bullock, K. M., Shi, M., and Zhang, J., Tau Proteins Cross the Blood-Brain Barrier., J Alzheimers Dis, vol. 55, no. 1, pp. 411-419, 2017.
J. P. Quinn, Corbett, N. J., Kellett, K. A. B., and Hooper, N. M., Tau Proteolysis in the Pathogenesis of Tauopathies: Neurotoxic Fragments and Novel Biomarkers., J Alzheimers Dis, vol. 63, no. 1, pp. 13-33, 2018.
B. H Kuiperij, Versleijen, A. A. M., Beenes, M., Verwey, N. A., Benussi, L., Paterlini, A., Binetti, G., Teunissen, C. E., Raaphorst, J., Schelhaas, H. J., Küsters, B., Pijnenburg, Y. A. L., Ghidoni, R., and Verbeek, M. M., Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot Study., J Alzheimers Dis, vol. 55, no. 2, pp. 585-595, 2017.
C. - C. Tan, Zhang, X. - Y., Tan, L., and Yu, J. - T., Tauopathies: Mechanisms and Therapeutic Strategies., J Alzheimers Dis, vol. 61, no. 2, pp. 487-508, 2018.
A. Sahoo, Bejanin, A., Murray, M. E., Tosakulwong, N., Weigand, S. D., Serie, A. M., Senjem, M. L., Machulda, M. M., Parisi, J. E., Boeve, B. F., Knopman, D. S., Petersen, R. C., Dickson, D. W., Whitwell, J. L., and Josephs, K. A., TDP-43 and Alzheimer's Disease Pathologic Subtype in Non-Amnestic Alzheimer's Disease Dementia., J Alzheimers Dis, vol. 64, no. 4, pp. 1227-1233, 2018.
M. E. Flanagan, Cholerton, B., Latimer, C. S., Hemmy, L. S., Edland, S. D., Montine, K. S., White, L. R., and Montine, T. J., TDP-43 Neuropathologic Associations in the Nun Study and the Honolulu-Asia Aging Study., J Alzheimers Dis, vol. 66, no. 4, pp. 1549-1558, 2018.
E. Z. Huie, Escudero, A., Saito, N., Harvey, D., Le Nguyen, M. -, Lucot, K. L., LaGrande, J., Mungas, D., DeCarli, C., Lamar, M., Schneider, J. A., Kapasi, A., Rissman, R. A., Teich, A. F., and Dugger, B. N., TDP-43 Pathology in the Setting of Intermediate and High Alzheimer's Disease Neuropathologic Changes: A Preliminary Evaluation Across Ethnoracial Groups., J Alzheimers Dis, vol. 91, no. 4, pp. 1291-1301, 2023.
R. Capozzo, Zoccolella, S., Frisullo, M. Elisa, Barone, R., Dell'Abate, M. Teresa, Barulli, M. Rosaria, Musio, M., Accogli, M., and Logroscino, G., Telemedicine for Delivery of Care in Frontotemporal Lobar Degeneration During COVID-19 Pandemic: Results from Southern Italy., J Alzheimers Dis, vol. 76, no. 2, pp. 481-489, 2020.
L. Fani, Hilal, S., Sedaghat, S., Broer, L., Licher, S., Arp, P. P., van Meurs, J. B. J., M Ikram, K., and M Ikram, A., Telomere Length and the Risk of Alzheimer's Disease: The Rotterdam Study., J Alzheimers Dis, vol. 73, no. 2, pp. 707-714, 2019.
K. N. H. Nudelman, Lin, J., Lane, K. A., Nho, K., Kim, S., Faber, K. M., Risacher, S. L., Foroud, T. M., Gao, S., Davis, J. W., Weiner, M. W., and Saykin, A. J., Telomere Shortening in the Alzheimer's Disease Neuroimaging Initiative Cohort., J Alzheimers Dis, vol. 71, no. 1, pp. 33-43, 2019.
M. Bilgel, Koscik, R. L., An, Y., Prince, J. L., Resnick, S. M., Johnson, S. C., and Jedynak, B. M., Temporal Order of Alzheimer's Disease-Related Cognitive Marker Changes in BLSA and WRAP Longitudinal Studies., J Alzheimers Dis, vol. 59, no. 4, pp. 1335-1347, 2017.
K. Planeta Kepp, Ten Challenges of the Amyloid Hypothesis of Alzheimer's Disease., J Alzheimers Dis, vol. 55, no. 2, pp. 447-457, 2017.
G. W. Rebok, Ball, K., Guey, L. T., Jones, R. N., Kim, H. - Y., King, J. W., Marsiske, M., Morris, J. N., Tennstedt, S. L., Unverzagt, F. W., and Willis, S. L., Ten-year effects of the advanced cognitive training for independent and vital elderly cognitive training trial on cognition and everyday functioning in older adults., J Am Geriatr Soc, vol. 62, no. 1, pp. 16-24, 2014.
S. G. Papageorgiou, Voskou, P., Economou, A., Beratis, I., and Douzenis, A., Testamentary Capacity Assessment Tool (TCAT): A Brief Instrument for Patients with Dementia., J Alzheimers Dis, vol. 61, no. 3, pp. 985-994, 2018.
C. Bussè, Caffarra, P., Rossi, A., Zorzi, G., Fragiacomo, F., Camporese, G., Pompanin, S., Di Bernardo, G. Antonio, and Cagnin, A., Testing Hippocampal Memory in Prodromal Dementia with Lewy Bodies., J Alzheimers Dis, vol. 64, no. 2, pp. 349-353, 2018.
V. Shukla, Seo, J., Binukumar, B. K., Amin, N. D., Reddy, P., Grant, P., Kuntz, S., Kesavapany, S., Steiner, J., Mishra, S. K., Tsai, L. - H., and Pant, H. C., TFP5, a Peptide Inhibitor of Aberrant and Hyperactive Cdk5/p25, Attenuates Pathological Phenotypes and Restores Synaptic Function in CK-p25Tg Mice., J Alzheimers Dis, vol. 56, no. 1, pp. 335-349, 2017.
M. W. Granger, Franko, B., Taylor, M. W., Messier, C., St George-Hyslop, P., and Bennett, S. A. L., A TgCRND8 Mouse Model of Alzheimer's Disease Exhibits Sexual Dimorphisms in Behavioral Indices of Cognitive Reserve., J Alzheimers Dis, vol. 51, no. 3, pp. 757-73, 2016.
J. Mendiola-Precoma, Padilla, K., Rodríguez-Cruz, A., Berumen, L. C., Miledi, R., and García-Alcocer, G., Theobromine-Induced Changes in A1 Purinergic Receptor Gene Expression and Distribution in a Rat Brain Alzheimer's Disease Model., J Alzheimers Dis, vol. 55, no. 3, pp. 1273-1283, 2017.
P. Han and Shi, J., A Theoretical Analysis of the Synergy of Amyloid and Tau in Alzheimer's Disease., J Alzheimers Dis, vol. 52, no. 4, pp. 1461-70, 2016.
R. Kandimalla and P Reddy, H., Therapeutics of Neurotransmitters in Alzheimer's Disease., J Alzheimers Dis, vol. 57, no. 4, pp. 1049-1069, 2017.
D. Angulo Sevilla, Rodríguez, M. Teresa Car, Rodríguez, P. Heredia, Sánchez, M. Fernández, Mora, J. Aurelio Vi, and Gago-Veiga, A. Beatriz, Is There a Characteristic Clinical Profile for Patients with Dementia and Sundown Syndrome?, J Alzheimers Dis, vol. 62, no. 1, pp. 335-346, 2018.

Pages